A decrease in liver S-adenosyl-L-methionine (SAM) content and an increase in ornithine decarboxylase (ODC) activity occurred between the 2nd and the 5th week after starting 2-acetylaminofluorene (AAF) feeding in diethylnitrosamine (DENA)-initiated rats. These rats then received a 0.05% phenobarbital (PB)-containing diet for 18 weeks after the end of AAF feeding. Two weeks after starting AAF, an increase in the hepatocyte labeling index '(LI) also occurred in y-glutamyl-transpeptidase (GGT)-positive foci and surrounding tissue. LI returned to control values in a few days in surrounding tissue, while it remained high for at least 4 weeks in the foci. Analogous changes were observed, but for a shorter period of time, in the rats subjected to partial hepatectomy (PH) plus AAF, in which no GGT-positive foci developed. Twenty-four weeks after starting AAF, 30% of the liver was occupied by visible nodules. ODC activity and LI were high and SAM was low in nodules, but they were near to control values in surrounding liver. SAM administration reconstituted the liver SAM pool, inhibited ODC activity, and prevented visible nodule development. SAM inhibition of ODC activity occurred in rifro only after preincubation with liver homogenate and was enhanced by adenine, an inhibitor of methylthioadenosine (MTA) phosphorylase. MTA addition to the reaction of mixture for ODC determination was inhibitory. The SAM decrease in both liver and nodules was coupled with a decrease of MTA content. SAM administration caused MTA accumulation in the liver. It is suggested that liver SAM content by influencing MTA level, could be a rate-limiting factor for growth and promotion, through a modulation of polyamine synthesis. (1 60-1 80 g) were housed individually in plastic cages and kept at constant hu-
INTRODUCHON
Polyamine biosynthesis is involved in the regulation of normal and neoplastic growth as well as in skin carcinogenesis promotion (8, 12, 21, 25) . An increase in rat liver ODC activity (2, 13, 23, 30), a key enzyme in polyamine synthesis (28), and a spermidine: spermine ratio (1 3) also occurs during liver hepatocarcinogenesis promotion. However, there is no evidence that this increase occurs only in the livers of animals subjected to the initiating and promoting stimuIus and not in those subjected to the promoting stimulus alone. In the latter animals, preneoplastic lesions are scanty (27) . Conseque,ntly, the effect of the presence of putative preneoplastic foci in the liver of rats subjected to the complete treatment (initiation plus promotion) could not be evaluated. A clue to the existence of a correlation be-* Presented at the Third Sardinian International Symposium, Octobcr 6-9, 1985 in Cagliari, Italy. tween polyamine synthesis and growth of putative preneoplastic foci, however, is represented by the observation that the main potent ODC inducers are those barbiturates that enhance the formation of GGT-positive foci when administered to DENAtreated rats (15). On the other hand, some known promoters, such as choline and methionine deficient diet (9, 18) and PB (6, lo), induce ODC activity (12) and cause a decrease of hepatic SAM content (1 6). Since SAM is an aminopropyl donor in the synthesis of spermine and spermidine (28), it seemed interesting to evaluate whether the promotion step of hepatocarcinogenesis may be regulated by variations of lipotrope content and if such variations may control polyamine synthesis.
FEO ET AL
TOXICOLOGIC PATHOLOGY midity (70%) and temperature (22°C) with a 12-hr photoperiod. They were placed in a standard high casein diet (Piccioni, Brescia), with water adlibittint.
Putative preneoplastic foci and hyperplastic nodules were produced by injecting the animals with a single necrogenic ip dose of DENA (1 50 mg/kg) followed, 2 weeks later, by a 2-week treatment with a diet containing 0.03% AAF. A PH was performed at the mid-point of this period (29) . At the end of AAF feeding, the rats were fed a standard diet containing 0.05% PB for 18 wk, and then received a standard diet until they were killed. SAM treatment was started at the end of AAF feeding and consisted of im injections every 4 hr of 25 mg/kg b.w. of a solution (20 mg/ml in Na,HPO,, final pH 5 ) of SAM in the form of disulfate p-toluene sulfonate (BioResearch, Liscate, Milano). Controls received the same amount of solvent with an equimolar mixture ofsulfuric acid and p-toluene sulfonic acid. PH was performed between 9 and 10 A.M. by removal of the medium and the left lobes comprising 2/3 of the liver. For histological examination, small pieces of liver, taken from each of the lobes, were frozen in isopentane at -140°C and cut at 5 pm in a cryostat, after embedding in Paraplast. After fixing the sections in cold acetone, GGT was determined according to Ruthenberg et a1 (1 9). Morphometric analysis was performed with the aid of a Leitz-TAS analysis system. LI and ODC activity determination and hepatocyte isolation were performed as described earlier (4, 14) . For HPLC determination of SAM and MTA the livers were homogenized in 2.5 vol of chilled HCIO.,. After centrifugation, aliquots of the supernatants were injected into HPLC (Perkin Elmer, Series 10) with an 84-S UV detector and a Partisil SCX 10 pm column (25 x 0.46 cm id.; Whatman Chem. Sep., Maidstone, Cleveland, OH). The column was maintained at room temperature, with a constant flow rate of 1 mumin and diluted with a 20-min linear gradient from 0 to 500 mhi ammonium formate buffer (pH 4). Effluent was monitored at 254 nm. SAM and MTA were eluted after 10.8 and 12.8 min, respectively, and measured by comparing the area of the peak in the tissue extract with that of standard solutions. Protein was determined as previously reported (5).
RESULTS AND DISCUSSION
As shown in Fig. 1 , the amount of GGT-positive liver was about 6% 1.5 weeks after starting AAF feeding and increased up to 40% in the following 6 weeks. This increase depended on a progressive rise in diameter and in number of GGT-positive foci (not shown). On the 24th week, GGT-positive foci represented only 12% of the liver, but at this time The arrow indicates the start of PB treatment weeks. The black histograms refer to SAM-treated rats. The black triangle refers to hyperplastic nodules. The abscissa represents time from the beginning ofAAF feeding. Data are means k SD of triplicate determinations with 6-12 rats. Student's t-test: SAM-treated different from control, between weeks 3 and 7, p < 0.01. Nodules different from control, p < 0.001. about 30% of the liver was constituted by visible nodules. The latter exhibited morphological features nearly identical to those described by Farber (1) for hyperplastic liver nodules. SAM treatment clearly reduced the amount of GGT-positive liver, which fell to about 17% 7 weeks after starting AAF. This effect was linked to a sharp decrease of both foci number and diameter (not shown). SAM treatment did not significantly affect the percentage of GGTpositive liver 24 weeks after starting AAF, but it completely inhibited the development of visible nodules. Fig. 2 illustrates the effect of exogenous SAM administration on ODC activity in the liver of carcinogen-treated rats. It appears that when a PH was performed a week after the start of AAF feeding, a sharp increase of ODC activity occurred in the 2nd week. Thereafter, the enzymatic activity rapidly decreased reaching the control activity in the 5th week. The association of the initiating stimulus with the promoting treatment resulted in a great increase in ODC activity in the 2nd week after starting AAF, followed by a further increase 1 week after initiating PB treatment. Thereafter, ODC activity progressively decreased. However, 7 weeks after initiating AAF feeding, ODC activity was still 2.3 times higher than control activity. It should be noted that in the 24th week, liver ODC activity was only slightly higher than control, but the activity in the nodule was 4 times higher than controls.
The increase in liver ODC activity during hepatocarcinogenesis promotion was paralleled by a rise in LI (Fig. 3) . Two weeks after starting AAF, LI was high both in surrounding liver and in GGT-positive foci. LI further increased in the 2.6th week (i.e., 4 days after starting PB treatment) in the foci, while -Omithine decarboxylase activity in carcinogen-treated liver. ODC activity was determined in the cytosolic fraction isolated from liver homogenates (histograms) or from nodule homogenates (black triangle). PB treatment was started when indicated by the arrow. The black histograms refer to SAM-treated rats. The abscissa represents the period of time from the beginning of AAF feeding. Data are means & SD of triplicate determinations with 2 or with 3-9 rats. Student's t-test: DENA/AAF/PH/ PB different from control, between weeks 2 and 24, p < 0.00 1. Nodules different from surrounding liver, p < 0.001. SAM-treated different from untreated, between weeks 3 and 24, p < 0.0 1.
it did not significantly change in the surrounding liver. A progressive decrease occurred in the following weeks, which led to a return to normal liver values (0.18 k 0.02 SD, n = 9) in the 3rd week in surrounding liver. However, in the 6th week LT was still 5 times higher in the foci than in surrounding liver. SAM treatment caused a large LI decrease in GGT-positive areas and in surrounding liver. In the 24th week GGT-positive foci did not exhibit any increase of LI with respect to control values. The latter, however, was 20 times higher in nodules than in control liver. It has been already reported (4, 7) that an increase in ODC activity and DNA synthesis is an early event that occurs within 12-24 hr after PH in the rats not subjected to carcinogens. Control values are restored in a few days. PB enhances both ODC activity and LI in hepatectomized rats, while SAM treatment inhibits them (4). Our data indicate that the promoting treatment, in animals not subjected to an initiating DENA dose, prolongs the period ofactive polyamine and DNA synthesis in hepatectomized rats. However, DENA injection, preceding the promoting treatment, apparently further prolongs the period of active polyamine and DNA synthesis. The high ODC activity in the liver of rats subjected to the complete treatment (initiation plus promotion) could depend on the presence of a growing putative preneoplastic tissue which nodules. Student's t-test: foci plus SAM different from foci without SAM at weeks 2.6 and 3, p < 0.01. Surrounding liver different from foci between weeks 2 and 6, p < 0.05. Surrounding liver plus SAM different from surrounding liver at weeks 2.6, p < 0.00 1. Nodules different from foci, p < 0.00 1.
contributes to the elevation of polyamine synthesis. Accordingly, liver ODC activity was observed to be high in the 3rd week after starting AAF feeding, when LI was low in surrounding liver yet still high in GGT-positive foci. Further, the inhibition ofODC activity by SAM was coupled with a decrease of GGT-positive liver and a prevention of the development of nodules.
In order to assess if SAM directly affects ODC, this enzymatic activity was studied in vitro in the presence of SAM. The data in Table I indicate that the addition of 5 mM SAM to the reaction medium used for the determination of ODC activity was without effect. In contrast, about 3.8% inhibition occurred when liver homogenate was incubated with the same amounts of SAM before isolating the soluble fraction used as a source of ODC. Analogous results were obtained when SAM was preincubated with hepatocytes isolated from normal rats. The addition of 5 mhi L-methionine plus 5 mhi adenosine to isolated hepatocytes, suspended in HAM-F12 medium, was only 20% as efficacious as SAM in inhibiting ODC activity (not shown). This could indicate that SAM enters liver cells without preliminary splitting to methionine and adenosine and that 112 FEO ET AL TOXICOLOGIC PATHOLOGY The homogenate was preincubated 60 min at 37°C. At the end of the incubation the homogenate was centrifugated to isolate the cytosolic fraction used as a source of enzyme. When indicated 5 mhi SAM, 2 mhi adenine and 1 mhf hlTA were added to the homogenate or to the reaction medium. Data are means f SD with the number of experiments between parentheses.
ODC activity in pmol CO,/hr/mg protein. Different from homogenate, p < 0.001. Different from non-preincubated control, p < 0.001. a SAM metabolite is responsible for the inhibition of ODC activity. MTA, one of the major SAM catabolites formed by direct splitting or during aminopropylation of putrescine and spermine (28) , is known to be a growth inhibitor (29) . MTA is subjected to phosphorolytic splitting with production of methylthioribose phosphate and adenine (28) . This reaction is catalyzed by a phosphorylase, which is inhibited by adenine (28) . The effect of MTA on ODC activity was investigated. The data in Table I indicate that MTA did not need pre-incubation with liver homogenate in order to inhibit ODC activity. Further, adenine significantly enhanced the inhibitory effect ofboth SAM and MTA. It thus seems that MTA is the SAM catabolite responsible for the in viw induced ODC inhibition by SAM. Consistent with this conclusion is the observation that the increase in liver ODC activity 3 and 5 weeks after starting AAF feeding in the rats subjected to the initiating plus promoting treatments (Table 11) was coupled with a great decrease of both SAM and MTA liver contents. Interestingly, in the 24th week, when liver ODC was slightly higher than control, both SAM and MTA underwent a relatively small decrease, while they were largely decreased in the visible nodules, whose ODC activity exhibited a 4-fold increase. SAM treatment almost completely reconstituted the control SAM pool, while it caused a large increase of MTA. This treatment was associated with a significant fall in ODC activity.
These observations indicate that variations of the SAM pool may influence the liver cell growth and the promotion process. This process is characterized by a decrease of hepatic SAM content. Such a decrease was observed using an experimental model for hepatocarcinogenesis promotion, which is not based on the administration of a choline and methionine deficient diet. On the other hand, food consumption between 2 and 7 weeks after starting AAF was 12.8 2 2.6 g/rat/day (SD, n = 29) for control rats and 14.0 k 1.2 g/rat/day (SD, n = 29) for the rats subjected to DENA/AAF/PH/PB. SAM treatment did not modify food intake. Thus, differences in food intake cannot explain the fall in SAM content of carcinogen-treated rats. Perhaps a decrease of liver SAM pool is not specific of the promotion by lipotrope-deficient diets (1 7). It may be assumed that growing tissues, either normal or preneoplastic, need relatively high amounts ofSAM for polyamine, nucleic acid, and phosphatidylcholine synthesis (20) . This results in a reduction of the SAM level and hence of MTA liver content. The administration of exogenous SAM leads to a reconstitution of the SAM pool, to an accumulation of MTA, and consequently, to the inhibition of growth. According to different observations, some enzymatic markers (3) and the growth (24) of putative preneoplastic liver undergo the same process, even if sometimes quantitatively different (3,25), including adaptive responses to PB as normal liver does. Our data show that the PB mitogenic stimulus on a putative preneoplastic population is higher and persists longer than that on surrounding liver. This could indicate that the population of selected hepatocytes overexpresses some adaptive responses, such as growth, to the promoter (28) . However, the foci of DNA synthesis and liver ODC activity, which underwent a rapid increase between 2 and 2.6 weeks after starting AAF feeding, subsequently underwent a progressive decrease. Twenty-four weeks after starting AAF, GGT-positive foci no longer exhibit an increase in DNA synthesis. Further, liver ODC activity is only slightly higher than control even if about 10% ofliver is still occupied by GGT-positive foci, a percentage that 2 weeks after starting AAF feeding is associated with a great increase of liver ODC activity. On the other hand, 24 weeks after starting AAF, i.e., 4 weeks after arresting PB treatment, visible nodules exhibit high DNA synthesis and ODC activity. It can therefore be suggested that most of the putative preneoplastic population progressively lose their growth capacity, and visible nodules derive from a selected population that permanently acquires a rapid growth capacity. Their development is therefore highly sensitive to growth inhibitors such as in viw treatment with SAM and an increase of the MTA cellular pool.
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